Table 1:

Baseline characteristics of the included patients

CharacteristicNo. (%) of patients*
De qi group
n = 167
Control group
n = 171
 Women69 (41.3)76 (44.4)
 Men98 (58.7)95 (55.6)
Age, yr, mean ± SD38.12 ± 12.7638.15 ± 12.75
Interval between onset of palsy and start of treatment
 ≤ 72 h108 (64.7)98 (57.3)
 > 72 to ≤ 168 h59 (35.3)73 (42.7)
House–Brackmann score
 28 (4.8)10 (5.9)
 388 (52.7)93 (54.4)
 454 (32.3)57 (33.3)
 517 (10.2)11 (6.4)
Facial Disability Index score, mean ± SD
 Physical function subscale64.82 ± 14.1367.84 ± 12.88
 Social/well-being subscale65.58 ± 14.8267.58 ± 12.46
WHO Quality of Life (brief version) score, mean ± SD
 Physical domain63.17 ± 13.1663.30 ± 12.29
 Psychological domain59.47 ± 10.9860.24 ± 10.36
 Social domain65.87 ± 14.0067.93 ± 11.82
 Environment domain60.78 ± 12.2160.71 ± 12.16
Education
 Junior middle school47 (28.1)49 (28.7)
 Senior middle school41 (24.6)41 (24.0)
 Junior college17 (10.2)19 (11.1)
 Bachelor59 (35.3)58 (33.9)
 Postgraduate3 (1.8)4 (2.3)
Occupation
 Civil servant5 (3.0)6 (3.5)
 Technician33 (19.8)35 (20.5)
 Clerk27 (16.2)30 (17.5)
 Service36 (21.6)24 (14.0)
 Worker10 (6.0)13 (7.6)
 Student32 (19.2)33 (19.3)
 Unemployed or retiree24 (14.4)30 (17.5)
Affected side
 Left85 (50.9)84 (49.1)
 Right82 (49.1)87 (50.9)
  • Note: SD = standard deviation, WHO = World Health Organization.

  • * Unless stated otherwise.

  • Used to assess facial-nerve function.